학술논문
O24 - Topic: AS08-Treatment/AS08g-Clinical trials - Phase II-III: APR 246 PLUS AZACITIDINE (AZA) IN TP53 MUTATED (M) MDS AND AML. LONG TERM FOLLOW UP OF PHASE 2 STUDY BY THE GFM
Document Type
Abstract
Author
Source
In Leukemia Research September 2021 108 Supplement
Subject
Language
ISSN
0145-2126